# EDGAR Filing Document

**Accession Number:** 0001907085
**File Stem:** 0001104659-26-001783
**Filing Date:** 2026-1
**Character Count:** 3110
**Document Hash:** a5f8f9252e1df3ecd1ecb6739cce7677
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-001783.hdr.sgml**: 20260107

**ACCESSION NUMBER**: 0001104659-26-001783

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260107

**FILED AS OF DATE**: 20260107

**DATE AS OF CHANGE**: 20260107

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oddity Tech Ltd
- **CENTRAL INDEX KEY:** 0001907085
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41745
- **FILM NUMBER:** 26515987

**BUSINESS ADDRESS:**
- **STREET 1:** 8 HAHARASH
- **CITY:** TEL AVIV-JAFFA
- **STATE:** L3
- **ZIP:** 6761304
- **BUSINESS PHONE:** (551) 751-7495

**MAIL ADDRESS:**
- **STREET 1:** 8 HAHARASH
- **CITY:** TEL AVIV-JAFFA
- **STATE:** L3
- **ZIP:** 6761304

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**Pursuant to Rule 13a-16 or 15d-16**

**under the Securities Exchange**

**Act of 1934**

For the month of January 2026

Commission File Number: 001-41745

**ODDITY Tech Ltd.**

(Translation of registrant's name into English)

**8 HaHarash Street, Tel Aviv-Jaffa, 6761304, Israel**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F⌧ Form 40-F ◻

**Other Events**

ODDITY Tech Ltd. (the "Company") today announces that Dr. Ido Bachelet is no longer employed with the Company. Dr. Bachelet formerly served as the Chief Science Officer of ODDITY LABS. His responsibilities have been assumed by other members of the ODDITY LABS leadership team. His departure is not the result of any disagreement regarding the Company's operations, policies, or practices. This organizational change is not expected to impact the Company's financial outlook or operations of ODDITY LABS, including the product development or commercialization timelines of any ongoing projects.

This Report on Form 6-K shall be deemed to be incorporated by reference into the Company's registration statement on [Form S-8 (Registration No. 333-274796)](http://www.sec.gov/Archives/edgar/data/1907085/000110465923105377/tm2327153d1_s8.htm) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **ODDITY TECH LTD.** | **ODDITY TECH LTD.** |
| By: | /s/ Lindsay Drucker Mann |
|  | Name: Lindsay Drucker Mann |
|  | Title: Global Chief Financial Officer |

---

Date: January 7, 2026